NYSE · Healthcare · Medical Instruments & Supplies · USA
Warby Parker Inc is a mid cap company (market value between $2 billion and $10 billion) in the Medical Instruments & Supplies industry.
Warby Parker is a lifestyle brand that designs and sells eyewear directly to consumers through its website and retail stores. The company offers prescription glasses, contacts, eye exams, and related services, along with technology-enabled features such as virtual try-on tools. It operates an integrated omnichannel platform combining digital commerce and physical locations across the United States.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the Warby Parker Inc stock.
Overvalued: intrinsic value $18.23 per share, market price $25.92, margin of safety -42.2% (as of 2026-11-17).
A 2.1x revenue multiple, discounted for its losses, values the shares at $18.23; the price of $25.92 is 42% above that value.
17 more funds hold it; the full list is part of the paid plan.
All 52 Medical Instruments & Supplies stocks
6 more in this industry show a wider margin of safety.
WRBY is overvalued (as of the 2026-11-17 close). A 2.1x revenue multiple, discounted for its losses, values the shares at $18.23; the price of $25.92 is 42% above that value.
$18.23 per share (as of the 2026-11-17 close), against a market price of $25.92. That is a margin of safety of -42.2%. The value comes from the one valuation method that applies to this company, recomputed every night after the US close.